Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Isabel Krsnik

11PUBLICATIONS

74CO-AUTHORS

Gene and molecular therapyEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 11, 2025

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|May 11, 2024

A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.

Rafael Ríos-Tamayo, Ramón Lecumberri, María Teresa Cibeira

|Jul 28, 2023

Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.

Laura Rosiñol, Albert Oriol, Rafael Ríos

|Mar 17, 2023

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.

Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig

|Feb 14, 2022

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.

Noemí Puig, María-Teresa Contreras, Cristina Agulló

|Jul 30, 2021

Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?

Ana Jiménez-Ubieto, Bruno Paiva, Noemi Puig

Pageof 2

Frequent Collaborators

7 joint publications

Juan-Jose Lahuerta

7 joint publications

Joaquín Martínez-López

7 joint publications

Albert Oriol

7 joint publications

Valentín Cabañas

7 joint publications

Jesús San Miguel

6 joint publications

Bruno Paiva

6 joint publications

María-Victoria Mateos

6 joint publications

Rafael Ríos-Tamayo

5 joint publications

Noemi Puig

5 joint publications

Miguel-Teodoro T Hernandez Garcia

Frequent Collaborators

7 joint publications

Juan-Jose Lahuerta

7 joint publications

Joaquín Martínez-López

7 joint publications

Albert Oriol

7 joint publications

Valentín Cabañas

Top Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on : Jul 24, 2013

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on : Jul 24, 2013

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos